Optimal iodine supplementation during antithyroid drug therapy for Graves’ disease is associated with lower recurrence rates than iodine restriction

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2265|88|3|473-478

ISSN: 0300-0664

Source: CLINICAL ENDOCRINOLOGY, Vol.88, Iss.3, 2018-03, pp. : 473-478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content